Skip to main content
. 2015 Mar 4;10(3):e0118830. doi: 10.1371/journal.pone.0118830

Table 1. Characteristics of relapsing-remitting multiple sclerosis (RRMS) patients included in this study.

Substudy-1 population Substudy-2 population Substudy-3 population Substudy-4 population
Untreated RRMS Discovery group Validation group
MBP responders MBP non-responders Untreated RRMS IFN-β treated RRMS Untreated RRMS IFN-β treated RRMS RRMS pre- and on IFN-β treatment Untreated RRMS IFN-β treated RRMS
Patient characteristics N 4 13 18 24 25 26 14 4 4
Age (years) 29 (26–36) 37 (32–42) 34 (27–41) 36 (32–40) 36 (29–41) 35 (32–44) 29 (26–37) NA NA
Female/male 3/1 8/5 14/4 18/6 18/8 16/9 8/6 NA NA
EDSS 0.5 (0–2) 1.0 (0.5–3) 1.5 (1.3–2.8) 1.5 (1.5–2.5) 2.0 (1.0–3.5) 2.5 (1.5–4) 1.0 (1.0–3.0) NA NA
Disease duration (years) 6.5 (2–11) 4 (2.5–6.5) 2.5 (1–8) 7 (4–10) 5 (4–9) 6 (5–10) 2(2–6) NA NA
Substudies Differentially expressed genes in DNA-array studies n = 4 n = 13 ND ND ND ND ND ND ND
T-cell proliferation (MBP) ND ND n = 13 n = 18 ND ND ND ND ND
T-cell proliferation (TT) ND ND N = 12 N = 18 ND ND ND ND ND
Intracellular cytokine T-cell assay ND ND n = 11 n = 22 ND ND ND ND ND
mRNA expression studies on CD4+ T-cells ND ND n = 11 n = 12 ND ND ND ND ND
mRNA expression studies on monocytes ND ND n = 11 n = 14 ND ND ND ND ND
mRNA-expression in whole blood using PCR ND ND ND ND n = 25 n = 26 n = 14 ND ND
mRNA-expression in whole blood and cell-subsets ND ND ND ND ND ND ND n = 4 n = 4

Values are given as median with interquartile range in parenthesis. RRMS = relapsing remitting multiple sclerosis; MBP = myelin basic protein; TT = tetanus toxoid; EDSS = Expanded Disability Status Scale; IFN-β = interferon-β; ND = not done; NA = not applicable.